(Q44179364)

English

Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'?

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'? (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Powles R

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sirohi B

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Kulkarni S

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Treleaven J

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Rudin C

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sankpal S

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Goyal S

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Horton C

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Millar B

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Saso R

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Singhal S

11

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mehta J

12

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

479-484

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

21 January 2018

Some early phase II trials in previously untreated multiple myeloma: The Royal Marsden experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

21 January 2018

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

21 January 2018

High-dose melphalan for multiple myeloma: long-term follow-up data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

21 January 2018

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

21 January 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

21 January 2018

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703682

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703682

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44179364&oldid=2206482307"